longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

HUALAN NPM: Signed a strategic cooperation agreement with Ganli Pharmaceutical, with an initial term of 3 years

Zhitong
Apr 22, 2025 at 07:45 AM

HUALAN NPM announced that the company has signed a strategic cooperation agreement with Ganli Pharmaceutical. Both parties are willing to establish a long-term friendly strategic partnership. The agreement will take effect after being signed and sealed by the legal representatives or authorized representatives of both parties, with an initial term of 3 years. During the initial term, Ganli Pharmaceutical intends to purchase 200 million bromobutyl rubber pistons for pen-type injectors from the company. This quantity is only a forecast and does not constitute a binding commitment. The specific procurement price and order quantity will be based on actual orders placed. The signed "Strategic Cooperation Agreement" is a long-term cooperation agreement and does not involve specific product amounts

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings

  • Sep 8, 2026 at 12:14 PMAI-era DCI: Beyond the chip, compete as a network. Is there a China play?

Related Stocks

HUALAN NPM

HUALAN NPM

SZ301093

-2.83%

Gan & Lee

Gan & Lee

SH603087

LongbridgeAI